Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2008
12/30/2008CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides
12/25/2008US20080319228 Method of fluorination
12/25/2008US20080319183 Branched Polymeric Sugars and Nucleotides Thereof
12/25/2008US20080319179 A nucleotide having a base attached to a detectable label through a cleavable linker; has a deoxyribose comprising a cleavable chemical group capping the 3' OH group of the deoxyribose and wherein both the cleavable linker and the capping cleavable chemical group are cleavable by light
12/25/2008US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
12/24/2008WO2008157751A2 Substituted imidazoheterocycles
12/24/2008WO2008157688A2 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
12/24/2008WO2008157438A1 Inhibitors of s-adenosyl-l-methionine decarboxylase
12/24/2008WO2008157319A1 ONCOGENIC ALL-1 FUSION PROTEINS FOR TARGETING DROSHA-MEDIATED microRNA PROCESSING
12/24/2008WO2008100447A3 Nucleoside analogs for antiviral treatment
12/24/2008WO2008099203A3 Reactions of isotopically enriched elements of phosphorus, sulfur, selenium and tellurium
12/24/2008EP2006293A2 2'-hydroxyl-modified ribonucleoside derivative
12/24/2008EP2004661A2 2'-fluoronucleoside phosphonates as antiviral agents
12/24/2008CA2692906A1 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
12/24/2008CA2691776A1 Substituted imidazoheterocycles
12/23/2008US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
12/23/2008US7468357 Nucleosides with anti-hepatitis B virus activity
12/23/2008US7468278 having pesticidal activity against insect pests, including Coleoptera
12/23/2008US7468243 2-aminopyrimidin-4-one nucleic acid labeling compounds
12/18/2008WO2008154639A2 Improved process for the production of nucleotide sugars
12/18/2008WO2008154629A1 Myeloid differentiation inducing agents
12/18/2008WO2008131062A3 Process for preparing capecitabine
12/18/2008US20080312428 Process for the Large Scale Production of Stavudine
12/18/2008US20080311667 Exogenous Markers for Oxidative Stress
12/18/2008US20080311186 Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome
12/18/2008US20080311037 Compounds which bind PSMA and uses thereof
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2690611A1 Improved process for the production of nucleotide sugars
12/17/2008EP2001896A2 Monomer compositions for the synthesis of rna, methods of synthesis, and methods of deprotection
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465734 Detecting potential therapeutic agent
12/16/2008US7465544 SAM analogs that are ligated to a methylation site by the methyltransferase
12/16/2008CA2299937C Synthetic medium for cultivating lactobacillus and bifidobacteria
12/11/2008WO2008151024A1 Protein kinase-binding nucleosides and associated methods
12/11/2008WO2008150729A2 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
12/11/2008CA2689310A1 Protein kinase-binding nucleosides and associated methods
12/11/2008CA2688321A1 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
12/10/2008EP1718659A4 Vectors having both isoforms of beta-hexosaminidase and uses of the same
12/10/2008CN101321775A ODCASE inhibitors for the treatment of malaria
12/09/2008US7462733 Preparation and use of α-keto phosphonates
12/09/2008US7462605 Phosphoramidate compounds and methods of use
12/09/2008CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
12/04/2008WO2008147454A1 Selective inhibitors of translesion dna replication
12/04/2008WO2008145403A1 Processes related to making capecitabine
12/04/2008WO2008144980A1 The preparation method and intermediates of capecitabine
12/04/2008WO2008144970A1 A novel and highly stereoselective process for preparing gemcitabine and intermediates thereof
12/04/2008WO2008144878A1 Continuous counter-current organosolv processing of lignocellulosic feedstocks
12/04/2008WO2008104408A3 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
12/04/2008US20080300399 Processes related to making capecitabine
12/04/2008US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV
12/04/2008US20080300216 Dutpase Inhibitors
12/04/2008US20080300215 Prodrugs Activated by Rna-Dependent Dna-Polymerases
12/03/2008EP1996020A2 Purine compounds and methods of use thereof
12/03/2008CN101316588A Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
12/03/2008CN100439387C Novel cytosine monophosphate medicine precursor
12/03/2008CN100439386C Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine
12/02/2008US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection
12/02/2008CA2278715C Aminooxy-modified oligonucleotides
12/02/2008CA2257803C Non immunosuppressive antifungal rapalogs
11/2008
11/27/2008WO2008144562A1 A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
11/27/2008WO2008144472A1 Novel chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides
11/27/2008WO2008144315A1 Methods and compositions for sequencing a nucleic acid
11/27/2008WO2008143846A1 Azido purine nucleosides for treatment of viral infections
11/27/2008WO2008143667A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
11/27/2008WO2008080060A3 4-se-thymidine derivatives, 4-se-uridine derivatives, di (2-cyanoethyl) diselenide, and methods
11/27/2008WO2008021225A3 Maize polymorphisms and methods of genotyping
11/27/2008WO2006034190A3 Purine derivatives and methods of use thereof
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293666 Antibacterial Agents
11/27/2008US20080293665 Purine Nucleotide Derivatives
11/27/2008US20080293648 Compositions and Methods for Cancer Treatment
11/27/2008US20080292553 Phosphoramidate Derivatives of Fau
11/27/2008US20080292550 Fluorinated 3'-Deoxythymidine Derivatives, a Method for Their Preparation and Their Use
11/27/2008US20080292548 Compounds and methods for 18f labeled agents
11/27/2008CA2687878A1 Antiviral agents
11/27/2008CA2685589A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
11/26/2008EP1995330A1 Modified oligonucleotides for mismatch discrimination
11/26/2008EP1995252A1 Method for removal of nucleic acid-protecting group
11/26/2008EP1994042A2 Preparation of gemcitabine
11/26/2008EP1931692B1 Selective o-acylation of nucleosides
11/26/2008CN100436468C A kind of compound, its pharmaceutical composition and its medicinal and health uses
11/25/2008US7456268 Purified morpholino modified oligonucleotide; anticarcinogenic and antitumor agents; medical diagnosis; wild-type p53-induced phosphatase1 (Wip1); gene expression inhibition; drug screening
11/25/2008US7456266 Detectable labeled nucleoside analogs and methods of use thereof
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7455974 Collection of nucleic acid fragments resulting from complete digestion of one or more nucleic acids by one or more restriction endonucleases; contains at least 3 fragments; and the size of the fragments in base pairs is a multiple of an integer of 10 or more
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/20/2008WO2008138389A1 A method of preparation of quaternary nitrogen compounds
11/20/2008US20080287671 2'(3')-O-((Phenylaminocarbonyl)-uridine 5'-)triphosphate, for example; useful in preventing thrombosis and restenosis, effective in inhibiting the contraction of vascular smooth muscle cells, inhibiting cell proliferation, and reducing inflammation
11/20/2008US20080287667 Nucleic Acid Labeling Compounds
11/20/2008US20080287378 Solid state forms of 5-azacytidine and processes for preparation thereof
11/20/2008US20080286837 comprise a label attached to the nitrogenous base portion of the analog via a cleavable linker at the N4, O4, N6 or O6 position; reversible inhibitors or blockers that allow the incorporation of only one nucleotide per addition cycle in a template-dependent sequencing-by-synthesis reaction
11/20/2008US20080286230 Compounds and pharmaceutical compositions for the treatment of viral infections
11/19/2008EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use
11/19/2008EP1992632A1 Method for the synthesis of cyclouridine
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
11/19/2008CN101307084A Synthetic process of decitabine
11/19/2008CN100434079C Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 201